ResolvebIo.com

Resolve Therapeutics was founded with the goal of advancing a novel biologic compound from preclinical research through a phase IIa biomarker study in systemic lupuserythmatosous.



Retrieved from "http://aboutus.com/index.php?title=ResolvebIo.com&oldid=20925530"